Humira, a biologic medication used to treat various autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and psoriasis, is a high-cost treatment that can benefit from significant insurance coverage [1][DrugPatentWatch.com][2].

The cost of Humira can range from $5,000 to $6,000 per year, making it unaffordable for some individuals. As such, insurance coverage plays a crucial role in determining the accessibility of this medication [3].

According to various reports, most insurance plans, including Medicare and Medicaid, cover Humira. However, the extent of coverage can vary significantly depending on the specific insurance plan [4].

Medicare, for example, covers Humira for the treatment of certain conditions. Medicare Part D, which covers prescription medications, includes Humira in its formulary, but the coverage may require patients to pay a portion of the cost, known as a copayment or coinsurance [5].

Similarly, many commercial insurance plans and employer-sponsored plans cover Humira, but the degree of coverage can differ greatly. Some plans may require patients to pay a copayment or coinsurance, while others may not cover it at all or require prior authorization [6].

Individuals seeking insurance coverage for Humira should discuss their specific situation with their insurance provider to determine the extent of coverage and any potential out-of-pocket costs associated with using this medication [7].

Sources:
1. https://www.drugpatentwatch.com/patent/US20100020060
2. https://www.drugpatentwatch.com/
3. https://www.healthcare.gov/
4. https://www.medicare.gov/
5. https://www.medicaid.gov/
6. https://www.healthcare.gov/commercial-insurance/
7. https://www.healthcare.gov/information-for-self-paying-consumers/